close
MENU
General Business
4 mins to read

Clinical trial companies merge under Pencarrow majority ownership

Combined company keen to target larger slice of global clinical trial market.

Will Mace Fri, 22 Oct 2021

An investment by Pencarrow Private Equity has brought together two regional clinical trial research companies to bolster their capabilities and target untapped growth in the Asia-Pacific market.

Lakeland Clinical Trials (LCT) of Rotorua and Southern Clinical Trials (SCT) of Christchurch have

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Will Mace Fri, 22 Oct 2021
Contact the Writer: william@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Clinical trial companies merge under Pencarrow majority ownership
General Business,
89359
true